
This is a FREE event.
Purpose
The KAT6A & KAT6B Virtual Symposium series is an initiative led by the KAT6A Foundation, designed to support patients and their families living with KAT6A and KAT6B related disorders.
The symposium aims to solidify current KAT6A & KAT6B research network amongst clinicians and researchers through identification of research opportunities and ongoing collaborations. By enabling a space that facilitates open dialogue in order to share resources, ideas and tools, the symposium also aims to spark new collaboration amongst researchers and health care professionals interested in KAT6A/B disorders.
The 2021 KAT6A & KAT6B symposium was the first collaborative research event organized by the KAT6A Foundation. Over 45 participants attended the virtual meeting which included 16 speakers invited to present their research related to KAT6A or KAT6B genes. In this meeting, domains of speech, language and communication were identified as significant health challenges by the KAT6A and KAT6B community.
The upcoming KAT6A & KAT6B symposium will focus on bringing together the speech and language experts working on rare genetic conditions and foster their connection with the foundation and families who have a child with KAT6A or KAT6B gene variation. Speakers will discuss many topics including neurological markers of speech and language impairments, neuroimaging in KAT6A/B disorders, animal models in speech and language research, pathways to treat children with apraxia, neuropsychological assessments, and parental perspective on navigating communication challenges.
Parents, caregivers, health care professionals, clinicians, researchers, and health administrators who are concerned with the care of children with rare genetic disorders are invited to register. All levels of skill will be addressed.
When
March 22nd, 8:00 pm- 11:00 pm GMT
Agenda
Session 1: KAT6A Foundation – Empowering Patient-centered Research and Collaboration
KAT6A Foundation’s Plan for 2022
Speakers: Emile Najm and Jordan Muller, KAT6A Foundation
KAT6A Foundations Research Collaborations
Speaker: Ying Weng, Tongji University, China
Session 2: Understanding the Pathophysiology of KAT6A and KAT6B Related Speech and Language Disorders
Distinguish Speech from Language. Understand the Spectrum of Speech and Language in KAT6A Gene Variations
Speaker: Miya St John, Murdoch Children’s Research Institute, Australia
Neuroimaging in KAT6A and KAT6B Related Disorders: Feasibility of Using Sophisticated Quantitative MRI Techniques to Understand the Impact of Variation in KAT6A or KAT6B Genes on Speech and Language Pathways
Speakers: Frederique Liegeois, University College of London, UK and Marc Seal, Murdoch Children’s Research Institute, Australia
Neurological Markers of Speech and Language Impairments in Rare Genetic Disorders
Speakers: Simon E Fisher, Radbound University, Netherlands and Kate Baker, University of Cambridge, UK
Animal Models in Speech and Language Research
Speaker: Anne Voss, Walter and Eliza Institute of Medical Research, Australia
Neuropsychological Assessment of Kids with Apraxia
Speaker: Emma Baker, Murdoch Children’s Research Institute, Australia
Pathways to Treat Children with Apraxia: Speech Therapist Perspective on Rare Genetic Disorders
Speaker: Patricia Wilson, Playworks therapy, USA
Parent Perspective on Navigating Speech, Language and Communication Challenges in Children with Rare Genetic Variation
Speaker: Typhaine Lejeune, Parent of a child with KAT6B gene variant and Board Member of the KAT6A Foundation